Covishield vaccine: India’s decision to increase gap between doses in sync with UK, WHO recommendations
Indeed, on April 30, Spain revised its national directive on the vaccine, saying those under 60 years of age who had received the first dose should get their second one only 12-16 weeks after.
Govt needs to free up the vaccination process
By keeping such tight price controls, govt is leaving little incentive for those delivering the vaccine to crores
Union Budget 2021: Vaccine-focus a shot in the arm
Union Budget 2021 India: “The continuing modest allocation towards the healthcare sector would make it challenging for the government to meet its target of public sector healthcare investment of 2.5% of the GDP by 2025,”
Supreme Court setting a dangerous precedent
Disgruntled groups, with enough clout to gherao Delhi, can now challenge any law and get it kept in abeyance
Vax Populi: Coronavirus vaccine truths and untruths
Bharat Biotech (BB) founder and chairman Dr Krishna Ella, on Monday, said that the approval for BB’s Covaxin was being dragged into a political controversy and that it was within the rules laid down by the government in 201
Oxford Covid vaccine safe, no major side effects: Study
Findings of the study, published in The Lancet, detail minor side effects like localised pain, feeling feverish, chills, muscle ache, and headache.
Covid-19: 249 million cases, 1.8 million deaths by March 2021; MIT researchers’ gloomy prediction
Coronavirus: In such a scenario — absent drugs and vaccines — non-pharmacological measures like hygiene, distancing and wearing masks have the most efficacy.
Testing myopia continues: Even for fast antigen tests, ICMR has restrictions on usage
The way to test the entire country is to do the kind of antibody tests or sero-surveys that ICMR did last month regularly to see which parts of the country are more likely to have a higher disease burden.
Coronavirus infection: Around 1 crore Indians were exposed, Sero-Survey finds
This is lower than in other countries, but is good news as it means fatality rates are just 0.08%
For a Moment of Taste: It’s vegan evangelism, targeted at consumers
For a Moment of Taste is vegan evangelism, targeted at consumers. A shift away from meat-eating will require engagement with other stakeholders
An army against COVID-19: How countries like Israel, South Korea, US are racing to develop Corona monoclonal antibodies
Israel has just reported a potent monoclonal antibody (mAb) against SARS CoV-2. Firms in South Korea, the US are leading mAb trials.
Fighting Corona: Look at local data, not a national curve
An RT-PCR test takes several hours for the result to be available. We cannot make a patient who comes with a non-Covid-19 problem wait till that result is available.
COVID-19: We need not be in chains, but we should not shed our armour, says PHFI’s Dr K Srinath Reddy
It is difficult to comment on a trend—the only thing that can be said with some degree of certainty is that asymptomatics are largely below 50-45 years of age.
COVID-19 crisis: Need social distancing for one year, says PHFI’s Dr K Srinath Reddy
Reddy spoke of how it is very difficult to catch asymptomatics, unless individuals get themselves tested on demand, or the public health authorities organise testing in a cluster.
Controlling COVID-19: To slay the Coronavirus-Goliath
CDDEP-Princeton-Johns Hopkins researchers estimate a mammoth hospitalisation problem from COVID-19 in India. Pushing out the peak,i.e. delaying its occurrence through lockdowns, seems the only workable strategy till a vaccine
India Coronavirus cases near 10,000: Flattening of COVID-19 curve still a little away
The 30th reported case is considered for the baseline since the growth in cases since the first reported case/clutch of cases has seen widely varying timelines.
Good and bad news from ICMR study
In either case, the study shows more testing as well as thorough mapping an investigation of contacts is required for a complete picture of the spread of the infection.
A longer lockdown? Here is what researchers have to say
A study by two India-origin researchers at the University of Cambridge, is based on the SIR approach, but takes into account age and social contact structure to assess the impact of the lockdown and social distancing measures
Use pooled testing to identify hotspots, lower number of Covid-19 tests: CDDEP
This will lower the number of tests to be conducted, while help identify corona hotspots faster, critical for any containment strategy.
Covid Crisis: If more than 1% Indians get infected, we will run out of hospital beds
At a 5% infection level, India may need to increase hospital beds by 4-5 times.
Johns Hopkins says CDDEP model is robust
The report, based on the lockdowns in effect in the country at the time of its drafting, estimates ~190 million infected at the peak of the Covid 19 outbreak in the country.
Coronavirus Outbreak: With no vaccine, nations rely on existing drugs
Without vaccines or a new cure, nations are relying on existing, approved drugs/vaccines for other diseases with mixed reports of efficacy.
Johns Hopkins says CDDEP Corona model robust
In a tweet, Johns Hopkins said, “The use of our logo was not authorized in this case and JHU is engaging with CDDEP on it”.
Coronavirus challenge: Govt planning 150-fold increase in COVID-19 testing
The ICMR has prioritised urgent delivery of the new kits, asking potential suppliers to state the maximum supply capability for the first week, at six locations.
Capital Crisis: Delhi COVID19 infections can cross 2 lakh, if quarantining is not effective, says ICMR
If quarantining is not effective, the number can be 10 million; nationwide lockdown instituted now can help reduce impact
ICMR approval: India okays use of FDC Kaletra to treat Covid
Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.
Delhi infections can cross 2 lakh: ICMR
If quarantining not effective, can be 1.5-10 million; nationwide lockdown instituted now can help reduce impact.
Advertisement
US Stock Market
View All- Cathie Wood’s ARK sells shares of Tesla, Facebook, Amazon, JD.com while adding more Twitter shares
- Inflation, China and Virus: What to watch while investing in stocks in 2022
- How to invest in FAANG stocks from India
- Facebook’s Meta ticker trades in Canada, ignores U.S. delay
- US stock futures rally as traders take Powell’s ‘Time to retire the word Transitory’ remark in their stride
Most Read
- Coronavirus Omicron India December 7 Highlights: Omicron Covid variant 'almost certainly' not more severe than Delta, says top US scientist Anthony Fauci
- Redmi Note 11T 5G review: Good looks, great battery life
- New opportunities for India-Turkey relations
- Share Market Highlights: Sensex closes 886 pts higher at 57,633, Nifty adds 264 pts to end at 17,176
- Covid-19 Vaccine Certificate: Here’s how to download it from CoWin portal, Aarogya Setu app
- Mumbai-Ahmedabad Bullet Train: Here's when you can board India's first high-speed rail
- Covid-19 vaccine: WHO to consider emergency use listing of Covovax next week
- Another milestone achieved by Indian Railways in under-construction Kashmir rail project; details here
- Bharat Petroleum Rating 'Buy'; No divestment premium in current price
- Ganga Expressway: Flagship project is ready to roll
Advertisement
Top News
- RBI MPC LIVE: RBI keeps policy rates unchanged, maintain status quo amid Omicron variant scare
- Market LIVE: Sensex above 58,300, Nifty nears 17,400, resistance near 17,550; IT stocks rally
- Covid LIVE: India records 8,439 new COVID-19 cases, 195 fatalities; US scientist Anthony Fauci says Omicron milder than previous variants
- Parliament Winter Session 2021 Live Updates: Crucial Bills in Lok Sabha today, Oppn to continue protest against suspension of Rajya Sabha MPs
- India 'poor and very unequal', top 1% of population holds 22% of national income: Inequality Report
- Reliance Industries, Spicejet, Vedanta, Hindustan Zinc, SBI among stocks in focus today
- Sebi may get to regulate private cryptocurrencies
- India-Russia ties multifaceted, but more ballast is needed on the economic front
- Keep handset, OTT revenues out of AGR: Telcos
- Sebi consultation paper: Towards investor protection and market stability
Advertisement
